Clinical Trial Update: Experimental Bone Marrow Transplant Protocol [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for an experimental bone marrow transplant protocol that investigated treatment in blood cancer conditions; study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Lymphocytic Leukemia
• Myelodysplastic Syndromes
• Myeloproliferative Disorders

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia | Phase 2 | Status: COMPLETED